التداخل بين أرفورموتيرول وتيمولول

Beta-blockers may decrease effectiveness.

In this setting, cardioselective beta-blockers could be considered, although they should be administered with caution.

Beta-Blockers Beta-adrenergic receptor antagonists (beta-blockers) and arformoterol tartrate inhalation solution may inhibit the effect of each other when administered concurrently.

Beta-blockers not only block the therapeutic effects of beta-agonists, but may produce severe bronchospasm in COPD patients.

Therefore, patients with COPD should not normally be treated with beta-blockers.